These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8455394)

  • 1. Hyperlipoproteinemia in adults with renal disease.
    Anderson CF
    Mayo Clin Proc; 1993 Apr; 68(4):358-62. PubMed ID: 8455394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):388. PubMed ID: 6337805
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term low-density lipoprotein immunoapheresis in renal disease.
    Derfler K
    Contrib Nephrol; 1997; 120():105-19. PubMed ID: 9257053
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperlipoproteinemia in renal insufficiency.
    Heuck CC; Ritz E
    Nephron; 1980; 25(1):1-7. PubMed ID: 6986036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia in renal failure: phenotypes and pathogenetic mechanisms.
    Riesen WF; Mordasini R
    Contrib Nephrol; 1984; 41():312-20. PubMed ID: 6396036
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hyperlipoproteinemia in congenital nephrotic syndrome of the Finnish type: effect of dialysis and kidney transplantation.
    Salo MK; Jaakkola O; Solakivi T; Ylä-Herttuala S
    Acta Paediatr; 1993 Sep; 82(9):768-72. PubMed ID: 8241675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].
    Hörl WH; Hörl M; Heidland A
    Klin Wochenschr; 1982 Apr; 60(7):327-36. PubMed ID: 6122754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J; Villabona C; Vilella E
    Nephron; 1993; 64(4):565-9. PubMed ID: 8366982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.
    Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB
    J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and treatment of dyslipidemia of renal diseases.
    Toto RD; Vega GL; Grundy SM
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyslipoproteinemia in kidney diseases].
    Wróblewska M; Król E
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):494-7. PubMed ID: 8170821
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma lipid alterations in patients with chronic renal disease.
    Cramp DG
    Crit Rev Clin Lab Sci; 1982; 17(1):77-101. PubMed ID: 6749432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.